SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is currently seeing intense volatility and bearish pressure as traders brace for upcoming FDA briefing documents and the subsequent advisory committee vote on its Duchenne muscular dystrophy therapy. The community remains deeply divided, with bulls pointing to the trial's statistical significance and potential patient impact, while bears highlight regulatory skepticism and pending legal challenges as major points of concern.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SPCX is seeing high volatility and intense social media debate as investors weigh the company's long-term potential against concerns over valuation, upcoming share lock-up expirations, and the impact of recent Starship launch results. While some community members are actively accumulating shares on dips, others are focusing on bearish sentiment driven by high short interest and questions regarding the stock's long-term sustainability.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors weigh an expanded partnership with AT&T against broader macro-driven volatility in high-beta tech stocks. While the community remains divided over valuation and the potential for a short-term pullback, bulls are highlighting recent government support and enterprise adoption as key indicators for long-term growth.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors digest executive orders aimed at accelerating U.S. quantum technology leadership and strengthening national security. While bulls highlight potential government funding and strategic importance, bears are actively debating the company's high cash burn rates, recent insider selling, and extreme valuation multiples relative to current enterprise revenue.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh strong U.S. commercial potential and a recent debt buyback against concerns regarding weak preliminary sales data and competitive pressures from AstraZeneca. The community is actively debating the significance of the upcoming annual shareholder meeting and EMA regulatory milestones, with long-term holders interpreting recent price volatility as a potential opportunity amid ongoing institutional accumulation.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently at the center of investor discussion following reports of a massive $500 billion multi-year AI infrastructure partnership with SK Group and ongoing talks regarding a $250 billion financing guarantee for an OpenAI data center project. While some community members view these expansive deals as validation of long-term AI infrastructure demand, others are expressing concern over the implications of such large-scale financing arrangements and continued bearish sentiment from high-profile investors.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing extreme volatility and heavy selling pressure as traders react to broad sector weakness, global geopolitical tensions, and pre-earnings de-risking. The community remains deeply divided, with bulls pointing to strong AI-driven fundamentals and upcoming company events as reasons to accumulate, while bears are actively highlighting the stock's breakdown in price action and shifting sentiment regarding memory supply cycles.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is experiencing extreme volatility and intense community debate surrounding its valuation relative to its Net Asset Value, fueled by the upcoming expiration of a lockup period for restricted shares. Traders are actively speculating on the fund's exposure to high-profile AI and aerospace companies while clashing over the discrepancy between current market prices and the underlying portfolio holdings.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending following a definitive agreement for its acquisition by Argenx in an all-cash transaction valued at $77 per share. The community is actively discussing the significant premium offered over recent volume-weighted average prices, with many noting that the market appears to be treating the acquisition as a near-certainty given the current trading proximity to the offer price.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to significant leadership changes, with the CEO stepping down amid a period of strong sales growth for its lead therapy, Carvykti. The community is actively debating whether this transition, alongside recent stock price volatility, signals an imminent buyout by partner Johnson & Johnson or a strategic shift to bolster its competitive position in the crowded multiple myeloma space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Industry Outlook Highlights nVent Electric, Forgent Power Solutions and Vicor

AI adoption, automation and infrastructure spending are driving demand in electronic components, with nVent Electric among stocks to watch.

3 Stocks to Buy From a Prospering Electronics Components Industry

The Zacks Electronics - Miscellaneous Components industry players like NVT, FPS and VICR are benefiting from the solid adoption of AI and the democratization of IoT.


NVT vs. VRT: Which Data Center Infrastructure Stock is a Better Buy?

nVent Electric gains an edge over Vertiv as strong data center demand, record backlog and a more attractive valuation strengthen its investment appeal.

nVent Electric Surges 49% YTD: Should You Still Buy the Stock?

NVT surges 49.3% YTD on strong data center and power utility demand, with expanding capacity and record backlog supporting its long-term growth outlook.

nVent Stock Outlook Gets a Boost From Data Center Demand Wave

NVT is benefiting from AI data center demand, expanding backlog and capacity investments that support its stronger 2026 growth outlook.

NVT Is Emerging as an AI Infrastructure Winner Beyond Liquid Cooling

nVent Electric is expanding beyond liquid cooling, leveraging AI infrastructure demand across power, enclosures and grid modernization markets.

Is NVT Stock Still Worth Buying After Its Huge Rally in 2026?

nVent Electric's strong 2026 rally is backed by higher guidance and record backlog, but premium valuation and cost pressures warrant a cautious approach.

Can Capacity Expansion Support nVent Electric's Next Growth Phase?

NVT is expanding manufacturing capacity and investing in new products to meet rising AI data center and power utility demand.

nVent Electric and Lululemon have been highlighted as Zacks Bull and Bear of the Day

nVent Electric is highlighted for record growth and AI-driven demand, while Lululemon faces slowing growth and margin pressure in the latest Zacks Bull and Bear outlook.

Bull of the Day: nVent Electric (NVT)

Favorable quarterly results that have reflected records have driven the stock's YTD momentum, with NVT crushing our consensus expectations in its latest release.

nVent Electric Plc engages in the provision of electrical connection and protection solutions. It operates through the following segments: Systems Protection and Electrical Connections. The Systems Protection Business segment includes enclosures, power distribution units, cooling solutions, both liquid and air, and control buildings and provide customers with products and solutions that protect electronics, systems, and data. The Electrical Connections Business segment includes power connections, cable management and electrical solutions. The company was founded on May 30, 2017 and is headquartered in London, the United Kingdom.

nVent Electric plc

Why Is FLNC Stock Rising Today?

Equity

Neutral Sentiment

U.S. - Iran negotiations

Earnings

FOMC meeting

Other (drop a comment)

This week brings a Federal Reserve rate decision, Q2 GDP and PCE inflation data, and earnings from $MSFT, $META, $AAPL, and $AMZN. What will be the biggest driver of the market this week? Vote and explain your reasoning in the comments.

What will be the main driver of the market this week? 
 
Explain your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NVTnVent Electric plc

Fundamentals

Latest NVT News